Clinical Trials Logo

Clinical Trial Summary

Some Primary Immune Deficiencies can be associated with an inflammatory bowel disease, mimicking Crohn disease : the Chronic Granulomatous Disease (CGD), the XIAP deficiency, and the TTC7A deficiency.

This inflammatory bowel disease is frequent but inconstant, raising questions about other factors contributing to the disease. The aim of our study is to analyze, describe and compare the gut microbiota of patients with those primary immune deficiency, with or without intestinal disease.

The investigators can expect, in the long term, to compare on a same patient, the gut microbiota evolution, and to assess the role of gut microbiota modifications on the onset of an inflammatory bowel disease.


Clinical Trial Description

The investigators will include patients (adults or children), with Primary Immune Deficiency (CGD, XIAP or TTC7A deficiencies), and they will collect feces samples from them.

In parallel, as control groups, patients with no inflammatory bowel disease and no primary immune deficiency will be included, and also patients suffering from Crohn's disease without known primary immune deficiency.

The laboratory collaborators will then realize analyzes on the microbiota collected for all patients.

The study team will then analyze the microbiota composition of the different types of patients, and try to identify some factors, associated with the appearance of an inflammatory disease on these patients. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02909244
Study type Observational
Source Imagine Institute
Contact
Status Completed
Phase N/A
Start date February 2015
Completion date February 2017

See also
  Status Clinical Trial Phase
Recruiting NCT01222741 - Studies of Disorders With Increased Susceptibility to Fungal Infections
Active, not recruiting NCT01981785 - Investigation of Immune Disorders and Deficiencies N/A